Tamyra A. Toole
General Counsel presso RUBIUS THERAPEUTICS
Profilo
Tamyra A.
Toole is currently the Vice President-Regulatory Affairs at Rubius Therapeutics, Inc. She previously worked as the Senior Director-Regulatory Affairs at NitroMed, Inc. from 2005 to 2008 and as the VP-Regulatory Affairs & Quality Assurance at Infinity Pharmaceuticals, Inc. from 2008 to 2017.
Ms. Toole has a graduate degree from The Catholic University of America and an undergraduate degree from Villanova University.
Posizioni attive di Tamyra A. Toole
| Società | Posizione | Inizio |
|---|---|---|
| RUBIUS THERAPEUTICS | General Counsel | 01/06/2018 |
Precedenti posizioni note di Tamyra A. Toole
| Società | Posizione | Fine |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | General Counsel | 01/01/2017 |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | General Counsel | 01/05/2008 |
Formazione di Tamyra A. Toole
| The Catholic University of America | Graduate Degree |
| Villanova University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Borsa valori
- Insiders
- Tamyra A. Toole
